When a patient is diagnosed with #neuromuscular disease, they begin a lifelong need for precise information and treatment. Genetic testing can help. With a genetic diagnosis, personalized care becomes more than just a buzzword; it becomes a reality tailored to each patient. Invitae’s comprehensive neuromuscular panel tests up to 230 genes associated with hereditary neuromuscular conditions. Learn more: https://invit.ae/459PH2y
Invitae
Biotechnology Research
San Francisco, CA 136,242 followers
Bringing comprehensive genetic information into mainstream medicine to improve healthcare.
About us
Invitae is a leading medical genetics company trusted by millions of patients and their providers to deliver timely genetic information using digital technology. We’re working to provide accurate and actionable answers to strengthen medical decision-making for individuals and their families. Invitae's genetics experts apply a rigorous approach to data and research, serving as the foundation of our mission to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Within each of us lies information coded in our DNA that can transform our health. Unlocking that potential requires highly specialized, multidisciplinary collaboration. Our world-class genetics experts drive the development of a highly complex system of tools and processes, including robotics, artificial intelligence, machine learning, and software engineering. All of this comes together to provide patients with accurate, reliable results that can help guide decisions across the healthcare journey and potentially change lives today and for the next generation. Our teammates are grounded in a universal sense of urgency and ownership. We believe in the team above the individual and celebrate freedom with accountability. Employees are encouraged to speak up, try new things and make decisions that push us forward. We provide all Invitaens with opportunities to grow and advance, supported by flexible work hours, unlimited paid time off, the ability to work anywhere for many roles and the satisfaction of doing meaningful work. At Invitae, we're putting patients' genetic insights where they belong—at the center of healthcare. And we're doing it together, with you. Join us.
- Website
-
http://www.invitae.com/
External link for Invitae
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- San Francisco, CA
- Type
- Public Company
- Specialties
- genomics, biotechnology, healthcare, oncology, cancer, cardiology, rare genetic disease, neurology, hematology, pediatric genetics, and genetic testing
Locations
-
Primary
1400 16th Street
San Francisco, CA 94103, US
-
1400 16th St
San Francisco, CA 94103, US
Employees at Invitae
Updates
-
Universal hereditary cancer #genetictesting has life-changing potential worldwide. Invitae is leading the way in working to transform healthcare and helping patients face their inherited risks with confidence. Learn more: https://invit.ae/4aQdztj
Transforming breast cancer care
https://vimeo.com/
-
#ASCO24 kicks off today! Don’t forget to stop by booth #17149 to learn why Invitae should be your hereditary cancer #genetictesting partner and how test results can help inform treatment decisions.
-
Attending #ASCO24? Stop by booth #17149 to learn why Invitae should be your hereditary cancer genetic testing partner and how test results can help inform treatment decisions. From the earliest point in your patient’s care to results and consultation, we’re with you in the here and now. #GeneticTesting #cancer #HereditaryCancer
-
This #WomensHealthMonth, consider how adding #genetictesting to routine wellness checks can help identify cancer risk early, supporting women as they prioritize their health amidst life’s daily pressures. Explore genetic testing for hereditary cancer risks today: https://invit.ae/3UTwLAq
-
We're excited to announce eight studies to be presented at #ASCO24. The clinical data demonstrates the importance of genetic testing for patients with various types of cancer. Learn more: https://invit.ae/3KfXX7r
-
There is still time to register: https://invit.ae/3ymIdNd
Reduce uncertainty in variant classification by leveraging the capabilities of evidence modeling. Join us for this live webinar presented on May 28 at 12 pm ET/9 am PT and earn CEUs by attending. #genetictesting #GCchat Register today: https://invit.ae/3ymIdNd
This content isn’t available here
Access this content and more in the LinkedIn app
-
We are excited to sponsor and present data next week at #ASCO24. This year, we’re especially looking forward to bringing you Invitae Reach™. Invitae Reach streamlines the #genetictesting process, offering customizable genetic testing solutions and integrating them into your existing workflow. Stop by booth #17149 anytime during the meeting to visit our representatives and learn more about #InvitaeReach. #HereditaryCancer
-
It’s Clinical Trials Day. Someday, routine health screenings could include genetic testing for heritable health risks. A new study from the eMERGE network seeks to remove barriers to genetic testing for diverse populations. It suggests ways #genetics can become part of common healthcare practice and help prevent conditions like cancer, heart disease and diabetes. Read more about how Invitae is contributing to this vital effort: https://invit.ae/3WVPrSy #CTD2024 #ClinicalTrialsDay
Innovative eMERGE study aims to address historical health inequities
blog.invitae.com
-
The future of healthcare depends on not just what we know now but what we can discover. Our genetics experts create highly advanced machine-learning approaches that evolve with science to pinpoint answers that can help inform treatments and power research. Join the evolution: https://invit.ae/4b1gKPI #InvitaeGeneration